Skip to content
LaunchIndex
Browse/2026/09/oculibria.com

Oculibria | Retinal Vascular Therapeutics

oculibria.com

LaunchIndex first observed Oculibria | Retinal Vascular Therapeutics (oculibria.com) live on 16 September 2026. View its launch screenshot, category, and verification evidence.

Screenshot of oculibria.com
Captured September 16, 2026 17:08 as part of the recorded launch evidence.
Observed launch story

A launch record built from evidence.

Oculibria | Retinal Vascular Therapeutics (oculibria.com) was first observed live on 16 September 2026.

Oculibria is a research-stage biotechnology company developing locally delivered therapeutics for diabetic retinopathy, focusing on retinal vascular stability and disease-responsive biological control.

Its profile is classified as Professional service within Health / Health and wellness.

Recorded evidence

What the launch signal contained.

First observed live
Previous state
No prior non-live observation
Last verified
Canonical host
oculibria.com
Category
Health / Health and wellness
Website type
Professional service
Observed title
Oculibria | Retinal Vascular Therapeutics
Observed description
Oculibria is developing locally delivered therapeutics for diabetic retinopathy, with a focus on retinal vascular stability and disease-responsive biological control.
Detected technologies
None detected
Screenshot captured
Evidence source
Browser observation · Local
Evidence confidence
93%
HTTP status
200
Website owner

Is this your website?

Claim this profile to add verified owner information.

Claim website
Community signal

What do you make of this launch?

Vote on the site and leave a short note for other people exploring the new web.

↑0Up
↓0Down

Join the discussion

Sign in with Google to vote or comment.

Sign in to participate

Comments

0 comments
No comments yet

Be the first to leave a useful observation.

Report an issueFlag spam, illegal or harmful content, or inaccurate information.

Reports are private and reviewed by the moderation team. No sign-in is required, so this report will be anonymous.

Private to moderators · 10–2,000 characters